Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXC8
|
ENSG00000037965.4 | homeobox C8 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXC8 | hg19_v2_chr12_+_54402790_54402832 | 0.34 | 6.4e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_-_46655538 | 9.32 |
ENST00000303383.3
|
SHCBP1
|
SHC SH2-domain binding protein 1 |
chr8_-_27695552 | 5.61 |
ENST00000522944.1
ENST00000301905.4 |
PBK
|
PDZ binding kinase |
chr1_-_153113927 | 5.58 |
ENST00000368752.4
|
SPRR2B
|
small proline-rich protein 2B |
chr1_+_120839412 | 5.15 |
ENST00000355228.4
|
FAM72B
|
family with sequence similarity 72, member B |
chr1_-_153066998 | 5.06 |
ENST00000368750.3
|
SPRR2E
|
small proline-rich protein 2E |
chr6_+_151646800 | 4.90 |
ENST00000354675.6
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr1_-_153085984 | 4.74 |
ENST00000468739.1
|
SPRR2F
|
small proline-rich protein 2F |
chr1_+_206138884 | 4.69 |
ENST00000341209.5
ENST00000607379.1 |
FAM72A
|
family with sequence similarity 72, member A |
chr1_+_45205478 | 4.65 |
ENST00000452259.1
ENST00000372224.4 |
KIF2C
|
kinesin family member 2C |
chr17_+_62223320 | 4.25 |
ENST00000580828.1
ENST00000582965.1 |
SNORA76
|
small nucleolar RNA, H/ACA box 76 |
chr1_-_153029980 | 4.16 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
chr19_-_43382142 | 3.96 |
ENST00000597058.1
|
PSG1
|
pregnancy specific beta-1-glycoprotein 1 |
chr1_+_45205498 | 3.85 |
ENST00000372218.4
|
KIF2C
|
kinesin family member 2C |
chr4_-_57524061 | 3.85 |
ENST00000508121.1
|
HOPX
|
HOP homeobox |
chr12_-_57634475 | 3.68 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
chr1_-_153013588 | 3.60 |
ENST00000360379.3
|
SPRR2D
|
small proline-rich protein 2D |
chr12_-_10978957 | 3.56 |
ENST00000240619.2
|
TAS2R10
|
taste receptor, type 2, member 10 |
chr1_+_152975488 | 3.49 |
ENST00000542696.1
|
SPRR3
|
small proline-rich protein 3 |
chrX_-_38080077 | 3.09 |
ENST00000378533.3
ENST00000544439.1 ENST00000432886.2 ENST00000538295.1 |
SRPX
|
sushi-repeat containing protein, X-linked |
chr1_+_152956549 | 3.05 |
ENST00000307122.2
|
SPRR1A
|
small proline-rich protein 1A |
chr1_-_6420737 | 3.05 |
ENST00000541130.1
ENST00000377845.3 |
ACOT7
|
acyl-CoA thioesterase 7 |
chr20_-_54967187 | 3.04 |
ENST00000422322.1
ENST00000371356.2 ENST00000451915.1 ENST00000347343.2 ENST00000395911.1 ENST00000395907.1 ENST00000441357.1 ENST00000456249.1 ENST00000420474.1 ENST00000395909.4 ENST00000395914.1 ENST00000312783.6 ENST00000395915.3 ENST00000395913.3 |
AURKA
|
aurora kinase A |
chr18_+_657578 | 2.93 |
ENST00000323274.10
|
TYMS
|
thymidylate synthetase |
chrX_+_135252050 | 2.88 |
ENST00000449474.1
ENST00000345434.3 |
FHL1
|
four and a half LIM domains 1 |
chr15_+_40674963 | 2.87 |
ENST00000448395.2
|
KNSTRN
|
kinetochore-localized astrin/SPAG5 binding protein |
chr17_-_34122596 | 2.75 |
ENST00000250144.8
|
MMP28
|
matrix metallopeptidase 28 |
chr2_+_234104079 | 2.64 |
ENST00000417661.1
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
chr12_-_95510743 | 2.61 |
ENST00000551521.1
|
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
chr18_+_61445007 | 2.59 |
ENST00000447428.1
ENST00000546027.1 |
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr2_+_158114051 | 2.57 |
ENST00000259056.4
|
GALNT5
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
chr9_+_116207007 | 2.53 |
ENST00000374140.2
|
RGS3
|
regulator of G-protein signaling 3 |
chr1_-_205391178 | 2.53 |
ENST00000367153.4
ENST00000367151.2 ENST00000391936.2 ENST00000367149.3 |
LEMD1
|
LEM domain containing 1 |
chr10_+_6779326 | 2.48 |
ENST00000417112.1
|
RP11-554I8.2
|
RP11-554I8.2 |
chr19_-_51456321 | 2.47 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
chr19_-_51456344 | 2.47 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
chr2_-_241396131 | 2.45 |
ENST00000404327.3
|
AC110619.2
|
Uncharacterized protein |
chr17_-_8113542 | 2.45 |
ENST00000578549.1
ENST00000535053.1 ENST00000582368.1 |
AURKB
|
aurora kinase B |
chr2_-_161056762 | 2.41 |
ENST00000428609.2
ENST00000409967.2 |
ITGB6
|
integrin, beta 6 |
chr15_+_40674920 | 2.36 |
ENST00000416151.2
ENST00000249776.8 |
KNSTRN
|
kinetochore-localized astrin/SPAG5 binding protein |
chr1_+_152881014 | 2.34 |
ENST00000368764.3
ENST00000392667.2 |
IVL
|
involucrin |
chr10_+_5238793 | 2.26 |
ENST00000263126.1
|
AKR1C4
|
aldo-keto reductase family 1, member C4 |
chr5_+_147691979 | 2.24 |
ENST00000274565.4
|
SPINK7
|
serine peptidase inhibitor, Kazal type 7 (putative) |
chr4_+_79472673 | 2.23 |
ENST00000264908.6
|
ANXA3
|
annexin A3 |
chrX_+_135251783 | 2.22 |
ENST00000394153.2
|
FHL1
|
four and a half LIM domains 1 |
chr15_+_59397275 | 2.21 |
ENST00000288207.2
|
CCNB2
|
cyclin B2 |
chr4_-_104119528 | 2.19 |
ENST00000380026.3
ENST00000503705.1 ENST00000265148.3 |
CENPE
|
centromere protein E, 312kDa |
chr15_-_63674034 | 2.19 |
ENST00000344366.3
ENST00000422263.2 |
CA12
|
carbonic anhydrase XII |
chr15_+_40675132 | 2.14 |
ENST00000608100.1
ENST00000557920.1 |
KNSTRN
|
kinetochore-localized astrin/SPAG5 binding protein |
chr13_-_60738003 | 2.11 |
ENST00000400330.1
ENST00000400324.4 |
DIAPH3
|
diaphanous-related formin 3 |
chr18_-_33077556 | 2.09 |
ENST00000589273.1
ENST00000586489.1 |
INO80C
|
INO80 complex subunit C |
chr8_-_91095099 | 2.08 |
ENST00000265431.3
|
CALB1
|
calbindin 1, 28kDa |
chr15_+_69706585 | 2.07 |
ENST00000559279.1
ENST00000395392.2 |
KIF23
|
kinesin family member 23 |
chr2_-_161056802 | 2.06 |
ENST00000283249.2
ENST00000409872.1 |
ITGB6
|
integrin, beta 6 |
chrX_+_135251835 | 2.04 |
ENST00000456445.1
|
FHL1
|
four and a half LIM domains 1 |
chr8_-_7638935 | 2.03 |
ENST00000528972.1
|
AC084121.16
|
proline rich 23 domain containing 2 |
chr15_-_74504597 | 1.99 |
ENST00000416286.3
|
STRA6
|
stimulated by retinoic acid 6 |
chr2_-_89292422 | 1.97 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr10_+_94352956 | 1.95 |
ENST00000260731.3
|
KIF11
|
kinesin family member 11 |
chr8_+_7397150 | 1.95 |
ENST00000533250.1
|
RP11-1118M6.1
|
proline rich 23 domain containing 1 |
chr15_-_74504560 | 1.91 |
ENST00000449139.2
|
STRA6
|
stimulated by retinoic acid 6 |
chr1_+_87012753 | 1.88 |
ENST00000370563.3
|
CLCA4
|
chloride channel accessory 4 |
chr8_-_133097902 | 1.87 |
ENST00000262283.5
|
OC90
|
Otoconin-90 |
chr13_-_60737898 | 1.87 |
ENST00000377908.2
ENST00000400319.1 ENST00000400320.1 ENST00000267215.4 |
DIAPH3
|
diaphanous-related formin 3 |
chr2_+_89890533 | 1.86 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
chr15_+_69706643 | 1.85 |
ENST00000352331.4
ENST00000260363.4 |
KIF23
|
kinesin family member 23 |
chr12_+_75874580 | 1.82 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr13_-_30881134 | 1.82 |
ENST00000380617.3
ENST00000441394.1 |
KATNAL1
|
katanin p60 subunit A-like 1 |
chr3_+_111630451 | 1.80 |
ENST00000495180.1
|
PHLDB2
|
pleckstrin homology-like domain, family B, member 2 |
chr5_+_38846101 | 1.76 |
ENST00000274276.3
|
OSMR
|
oncostatin M receptor |
chr9_-_21305312 | 1.76 |
ENST00000259555.4
|
IFNA5
|
interferon, alpha 5 |
chr12_+_15475331 | 1.76 |
ENST00000281171.4
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O |
chr4_-_90756769 | 1.75 |
ENST00000345009.4
ENST00000505199.1 ENST00000502987.1 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr21_-_31869451 | 1.75 |
ENST00000334058.2
|
KRTAP19-4
|
keratin associated protein 19-4 |
chr12_-_6960407 | 1.75 |
ENST00000540683.1
ENST00000229265.6 ENST00000535406.1 ENST00000422785.3 |
CDCA3
|
cell division cycle associated 3 |
chr2_+_201450591 | 1.74 |
ENST00000374700.2
|
AOX1
|
aldehyde oxidase 1 |
chr6_+_151561085 | 1.72 |
ENST00000402676.2
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr20_-_1309809 | 1.71 |
ENST00000360779.3
|
SDCBP2
|
syndecan binding protein (syntenin) 2 |
chr8_+_31497271 | 1.71 |
ENST00000520407.1
|
NRG1
|
neuregulin 1 |
chr3_-_149095652 | 1.69 |
ENST00000305366.3
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr2_+_102456277 | 1.69 |
ENST00000421882.1
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4 |
chr13_+_109248500 | 1.68 |
ENST00000356711.2
|
MYO16
|
myosin XVI |
chr4_+_8201091 | 1.68 |
ENST00000382521.3
ENST00000245105.3 ENST00000457650.2 ENST00000539824.1 |
SH3TC1
|
SH3 domain and tetratricopeptide repeats 1 |
chr15_+_67418047 | 1.66 |
ENST00000540846.2
|
SMAD3
|
SMAD family member 3 |
chr11_+_55578854 | 1.61 |
ENST00000333973.2
|
OR5L1
|
olfactory receptor, family 5, subfamily L, member 1 |
chr2_-_89247338 | 1.61 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr2_+_11864458 | 1.60 |
ENST00000396098.1
ENST00000396099.1 ENST00000425416.2 |
LPIN1
|
lipin 1 |
chr2_-_111435610 | 1.59 |
ENST00000447014.1
ENST00000420328.1 ENST00000535254.1 ENST00000409311.1 ENST00000302759.6 |
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase |
chr5_+_159848854 | 1.58 |
ENST00000517480.1
ENST00000520452.1 ENST00000393964.1 |
PTTG1
|
pituitary tumor-transforming 1 |
chr3_-_189840223 | 1.58 |
ENST00000427335.2
|
LEPREL1
|
leprecan-like 1 |
chr14_+_56584414 | 1.56 |
ENST00000559044.1
|
PELI2
|
pellino E3 ubiquitin protein ligase family member 2 |
chr19_+_39903185 | 1.55 |
ENST00000409794.3
|
PLEKHG2
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
chr4_-_90757364 | 1.53 |
ENST00000508895.1
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr10_+_62538089 | 1.53 |
ENST00000519078.2
ENST00000395284.3 ENST00000316629.4 |
CDK1
|
cyclin-dependent kinase 1 |
chr14_-_94421923 | 1.53 |
ENST00000555507.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
chr2_-_169769787 | 1.53 |
ENST00000451987.1
|
SPC25
|
SPC25, NDC80 kinetochore complex component |
chr6_-_131321863 | 1.52 |
ENST00000528282.1
|
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
chr1_+_152957707 | 1.50 |
ENST00000368762.1
|
SPRR1A
|
small proline-rich protein 1A |
chr10_-_10836919 | 1.50 |
ENST00000602763.1
ENST00000415590.2 ENST00000434919.2 |
SFTA1P
|
surfactant associated 1, pseudogene |
chr11_+_5410607 | 1.48 |
ENST00000328611.3
|
OR51M1
|
olfactory receptor, family 51, subfamily M, member 1 |
chr7_+_142458507 | 1.47 |
ENST00000492062.1
|
PRSS1
|
protease, serine, 1 (trypsin 1) |
chr5_+_110074685 | 1.45 |
ENST00000355943.3
ENST00000447245.2 |
SLC25A46
|
solute carrier family 25, member 46 |
chrX_+_99899180 | 1.45 |
ENST00000373004.3
|
SRPX2
|
sushi-repeat containing protein, X-linked 2 |
chr12_+_110011571 | 1.44 |
ENST00000539696.1
ENST00000228510.3 ENST00000392727.3 |
MVK
|
mevalonate kinase |
chr14_-_107083690 | 1.44 |
ENST00000455737.1
ENST00000390629.2 |
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
chr18_+_21529811 | 1.44 |
ENST00000588004.1
|
LAMA3
|
laminin, alpha 3 |
chr8_-_62559366 | 1.44 |
ENST00000522919.1
|
ASPH
|
aspartate beta-hydroxylase |
chr10_-_90712520 | 1.43 |
ENST00000224784.6
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr11_-_124311054 | 1.42 |
ENST00000328064.2
|
OR8B8
|
olfactory receptor, family 8, subfamily B, member 8 |
chr13_+_34392185 | 1.41 |
ENST00000380071.3
|
RFC3
|
replication factor C (activator 1) 3, 38kDa |
chr11_-_58345569 | 1.39 |
ENST00000528954.1
ENST00000528489.1 |
LPXN
|
leupaxin |
chr6_+_24775641 | 1.37 |
ENST00000378054.2
ENST00000476555.1 |
GMNN
|
geminin, DNA replication inhibitor |
chr4_+_156680143 | 1.36 |
ENST00000505154.1
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
chr11_+_35198118 | 1.33 |
ENST00000525211.1
ENST00000526000.1 ENST00000279452.6 ENST00000527889.1 |
CD44
|
CD44 molecule (Indian blood group) |
chr17_-_39553844 | 1.32 |
ENST00000251645.2
|
KRT31
|
keratin 31 |
chr15_-_34628951 | 1.32 |
ENST00000397707.2
ENST00000560611.1 |
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
chr1_-_85514120 | 1.32 |
ENST00000370589.2
ENST00000341115.4 ENST00000370587.1 |
MCOLN3
|
mucolipin 3 |
chr2_-_89521942 | 1.32 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
chr7_-_107443652 | 1.32 |
ENST00000340010.5
ENST00000422236.2 ENST00000453332.1 |
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3 |
chr15_-_63674218 | 1.30 |
ENST00000178638.3
|
CA12
|
carbonic anhydrase XII |
chr12_+_21525818 | 1.30 |
ENST00000240652.3
ENST00000542023.1 ENST00000537593.1 |
IAPP
|
islet amyloid polypeptide |
chr1_-_54303949 | 1.30 |
ENST00000234725.8
|
NDC1
|
NDC1 transmembrane nucleoporin |
chr14_+_20937538 | 1.29 |
ENST00000361505.5
ENST00000553591.1 |
PNP
|
purine nucleoside phosphorylase |
chr6_-_131277510 | 1.28 |
ENST00000525193.1
ENST00000527659.1 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
chr19_-_56826157 | 1.28 |
ENST00000592509.1
ENST00000592679.1 ENST00000588442.1 ENST00000593106.1 ENST00000587492.1 ENST00000254165.3 |
ZSCAN5A
|
zinc finger and SCAN domain containing 5A |
chr19_+_42301079 | 1.27 |
ENST00000596544.1
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3 |
chr1_+_17559776 | 1.27 |
ENST00000537499.1
ENST00000413717.2 ENST00000536552.1 |
PADI1
|
peptidyl arginine deiminase, type I |
chr6_-_27114577 | 1.26 |
ENST00000356950.1
ENST00000396891.4 |
HIST1H2BK
|
histone cluster 1, H2bk |
chr11_-_128457446 | 1.26 |
ENST00000392668.4
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
chr10_+_54074033 | 1.25 |
ENST00000373970.3
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1 |
chr1_-_157670647 | 1.25 |
ENST00000368184.3
|
FCRL3
|
Fc receptor-like 3 |
chr5_+_89770664 | 1.24 |
ENST00000503973.1
ENST00000399107.1 |
POLR3G
|
polymerase (RNA) III (DNA directed) polypeptide G (32kD) |
chr5_+_89770696 | 1.24 |
ENST00000504930.1
ENST00000514483.1 |
POLR3G
|
polymerase (RNA) III (DNA directed) polypeptide G (32kD) |
chr5_+_135385202 | 1.23 |
ENST00000514554.1
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chr12_-_8803128 | 1.23 |
ENST00000543467.1
|
MFAP5
|
microfibrillar associated protein 5 |
chr3_-_47950745 | 1.22 |
ENST00000429422.1
|
MAP4
|
microtubule-associated protein 4 |
chr11_+_35201826 | 1.22 |
ENST00000531873.1
|
CD44
|
CD44 molecule (Indian blood group) |
chr3_-_197025447 | 1.22 |
ENST00000346964.2
ENST00000357674.4 ENST00000314062.3 ENST00000448528.2 ENST00000419553.1 |
DLG1
|
discs, large homolog 1 (Drosophila) |
chr4_-_69536346 | 1.21 |
ENST00000338206.5
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15 |
chr20_-_56286479 | 1.20 |
ENST00000265626.4
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
chr12_-_8814669 | 1.19 |
ENST00000535411.1
ENST00000540087.1 |
MFAP5
|
microfibrillar associated protein 5 |
chr18_+_21269404 | 1.19 |
ENST00000313654.9
|
LAMA3
|
laminin, alpha 3 |
chr14_+_67291158 | 1.19 |
ENST00000555456.1
|
GPHN
|
gephyrin |
chr12_-_48164812 | 1.19 |
ENST00000549151.1
ENST00000548919.1 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr5_+_54398463 | 1.19 |
ENST00000274306.6
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
chr7_+_134528635 | 1.18 |
ENST00000445569.2
|
CALD1
|
caldesmon 1 |
chr2_-_242626127 | 1.18 |
ENST00000445261.1
|
DTYMK
|
deoxythymidylate kinase (thymidylate kinase) |
chr12_-_8043736 | 1.17 |
ENST00000539924.1
|
SLC2A14
|
solute carrier family 2 (facilitated glucose transporter), member 14 |
chr19_+_54926601 | 1.17 |
ENST00000301194.4
|
TTYH1
|
tweety family member 1 |
chr17_-_38574169 | 1.16 |
ENST00000423485.1
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa |
chr6_+_53883790 | 1.16 |
ENST00000509997.1
|
MLIP
|
muscular LMNA-interacting protein |
chr11_+_12308447 | 1.15 |
ENST00000256186.2
|
MICALCL
|
MICAL C-terminal like |
chr6_+_47666275 | 1.14 |
ENST00000327753.3
ENST00000283303.2 |
GPR115
|
G protein-coupled receptor 115 |
chr12_+_113344755 | 1.14 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr22_+_45148432 | 1.13 |
ENST00000389774.2
ENST00000396119.2 ENST00000336963.4 ENST00000356099.6 ENST00000412433.1 |
ARHGAP8
|
Rho GTPase activating protein 8 |
chr17_+_4853442 | 1.13 |
ENST00000522301.1
|
ENO3
|
enolase 3 (beta, muscle) |
chr5_-_146781153 | 1.13 |
ENST00000520473.1
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chr19_-_7058651 | 1.12 |
ENST00000333843.4
|
MBD3L3
|
methyl-CpG binding domain protein 3-like 3 |
chr14_-_106066376 | 1.11 |
ENST00000412518.1
ENST00000428654.1 ENST00000427543.1 ENST00000420153.1 ENST00000577108.1 ENST00000576077.1 |
AL928742.12
IGHE
|
AL928742.12 immunoglobulin heavy constant epsilon |
chr10_+_62538248 | 1.11 |
ENST00000448257.2
|
CDK1
|
cyclin-dependent kinase 1 |
chr3_+_42897512 | 1.10 |
ENST00000493193.1
|
ACKR2
|
atypical chemokine receptor 2 |
chr1_-_54303934 | 1.09 |
ENST00000537333.1
|
NDC1
|
NDC1 transmembrane nucleoporin |
chr1_-_156571254 | 1.09 |
ENST00000438976.2
ENST00000334588.7 ENST00000368232.4 ENST00000415314.2 |
GPATCH4
|
G patch domain containing 4 |
chr1_+_196857144 | 1.08 |
ENST00000367416.2
ENST00000251424.4 ENST00000367418.2 |
CFHR4
|
complement factor H-related 4 |
chr6_-_150346607 | 1.08 |
ENST00000367341.1
ENST00000286380.2 |
RAET1L
|
retinoic acid early transcript 1L |
chr4_-_68749745 | 1.08 |
ENST00000283916.6
|
TMPRSS11D
|
transmembrane protease, serine 11D |
chr11_+_57310114 | 1.07 |
ENST00000527972.1
ENST00000399154.2 |
SMTNL1
|
smoothelin-like 1 |
chr12_+_53662073 | 1.07 |
ENST00000553219.1
ENST00000257934.4 |
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae) |
chr10_-_58120996 | 1.07 |
ENST00000361148.6
ENST00000395405.1 ENST00000373944.3 |
ZWINT
|
ZW10 interacting kinetochore protein |
chr11_-_55703876 | 1.07 |
ENST00000301532.3
|
OR5I1
|
olfactory receptor, family 5, subfamily I, member 1 |
chr1_-_152386732 | 1.06 |
ENST00000271835.3
|
CRNN
|
cornulin |
chr7_+_107224364 | 1.06 |
ENST00000491150.1
|
BCAP29
|
B-cell receptor-associated protein 29 |
chr5_-_125930929 | 1.06 |
ENST00000553117.1
ENST00000447989.2 ENST00000409134.3 |
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1 |
chr16_-_10868853 | 1.05 |
ENST00000572428.1
|
TVP23A
|
trans-golgi network vesicle protein 23 homolog A (S. cerevisiae) |
chr18_-_19994830 | 1.02 |
ENST00000525417.1
|
CTAGE1
|
cutaneous T-cell lymphoma-associated antigen 1 |
chr5_-_150948414 | 1.02 |
ENST00000261800.5
|
FAT2
|
FAT atypical cadherin 2 |
chr2_+_211342432 | 1.02 |
ENST00000430249.2
|
CPS1
|
carbamoyl-phosphate synthase 1, mitochondrial |
chr15_-_101835110 | 1.01 |
ENST00000560496.1
|
SNRPA1
|
small nuclear ribonucleoprotein polypeptide A' |
chr14_-_106967788 | 1.01 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
chr17_+_33914460 | 1.01 |
ENST00000537622.2
|
AP2B1
|
adaptor-related protein complex 2, beta 1 subunit |
chr10_-_10836865 | 1.01 |
ENST00000446372.2
|
SFTA1P
|
surfactant associated 1, pseudogene |
chr12_+_97306295 | 1.01 |
ENST00000457368.2
|
NEDD1
|
neural precursor cell expressed, developmentally down-regulated 1 |
chr12_-_772901 | 1.01 |
ENST00000305108.4
|
NINJ2
|
ninjurin 2 |
chr2_+_242811874 | 1.00 |
ENST00000343216.3
|
CXXC11
|
CXXC finger protein 11 |
chr11_+_35198243 | 1.00 |
ENST00000528455.1
|
CD44
|
CD44 molecule (Indian blood group) |
chr7_-_99277610 | 0.99 |
ENST00000343703.5
ENST00000222982.4 ENST00000439761.1 ENST00000339843.2 |
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5 |
chr12_+_75874460 | 0.99 |
ENST00000266659.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr4_+_156680153 | 0.99 |
ENST00000502959.1
ENST00000505764.1 ENST00000507146.1 ENST00000264424.8 ENST00000503520.1 |
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
chr1_-_198509804 | 0.98 |
ENST00000489986.1
ENST00000367382.1 |
ATP6V1G3
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 |
chr5_-_77844974 | 0.98 |
ENST00000515007.2
|
LHFPL2
|
lipoma HMGIC fusion partner-like 2 |
chr6_+_53883708 | 0.97 |
ENST00000514921.1
ENST00000274897.5 ENST00000370877.2 |
MLIP
|
muscular LMNA-interacting protein |
chr6_+_134758827 | 0.97 |
ENST00000431422.1
|
LINC01010
|
long intergenic non-protein coding RNA 1010 |
chr4_+_88532028 | 0.97 |
ENST00000282478.7
|
DSPP
|
dentin sialophosphoprotein |
chr1_-_222763240 | 0.97 |
ENST00000352967.4
ENST00000391882.1 ENST00000543857.1 |
TAF1A
|
TATA box binding protein (TBP)-associated factor, RNA polymerase I, A, 48kDa |
chr15_-_22448819 | 0.96 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr11_-_89653576 | 0.96 |
ENST00000420869.1
|
TRIM49D1
|
tripartite motif containing 49D1 |
chr6_-_108145499 | 0.96 |
ENST00000369020.3
ENST00000369022.2 |
SCML4
|
sex comb on midleg-like 4 (Drosophila) |
chr7_-_76247617 | 0.96 |
ENST00000441393.1
|
POMZP3
|
POM121 and ZP3 fusion |
chr3_+_57882024 | 0.95 |
ENST00000494088.1
|
SLMAP
|
sarcolemma associated protein |
chr16_+_57279004 | 0.94 |
ENST00000219204.3
|
ARL2BP
|
ADP-ribosylation factor-like 2 binding protein |
chr4_+_144354644 | 0.94 |
ENST00000512843.1
|
GAB1
|
GRB2-associated binding protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.0 | GO:1900195 | spindle assembly involved in female meiosis I(GO:0007057) positive regulation of oocyte maturation(GO:1900195) |
1.0 | 3.9 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.9 | 2.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.9 | 8.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.8 | 4.9 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.8 | 4.1 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
0.8 | 2.4 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.8 | 2.4 | GO:0071789 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.8 | 2.3 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.8 | 3.9 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.8 | 3.0 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.7 | 4.7 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.7 | 3.3 | GO:1903282 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.6 | 2.6 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.6 | 0.6 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.6 | 1.3 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.6 | 3.5 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.6 | 2.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.5 | 1.6 | GO:2000816 | negative regulation of mitotic sister chromatid segregation(GO:0033048) negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.5 | 2.5 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.5 | 1.5 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.5 | 1.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.5 | 7.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.5 | 6.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 3.5 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.4 | 1.7 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.4 | 2.5 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
0.4 | 1.3 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.4 | 4.5 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.4 | 28.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.4 | 1.2 | GO:0018315 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.4 | 3.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 1.5 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.4 | 2.2 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.4 | 1.4 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.4 | 1.1 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.4 | 2.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.3 | 1.7 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.3 | 1.7 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.3 | 0.6 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.3 | 0.9 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.3 | 1.2 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.3 | 1.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 2.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.3 | 1.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 1.9 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.3 | 1.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 1.3 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.3 | 0.8 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.3 | 2.6 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.3 | 1.8 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 1.0 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
0.3 | 1.3 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 0.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 1.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.2 | 1.7 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.2 | 0.2 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.2 | 0.7 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.2 | 2.3 | GO:0072025 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
0.2 | 5.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 1.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 1.4 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.2 | 0.7 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.2 | 0.7 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 0.7 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.2 | 1.7 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.2 | 0.8 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.2 | 0.6 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 1.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.2 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.2 | 0.6 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.2 | 1.2 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 0.8 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.2 | 0.9 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 2.8 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.2 | 0.6 | GO:0002188 | translation reinitiation(GO:0002188) |
0.2 | 2.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 0.9 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.2 | 0.4 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.2 | 0.7 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 2.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 1.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 1.4 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 0.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.2 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.2 | 1.0 | GO:0051012 | microtubule sliding(GO:0051012) |
0.2 | 0.8 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 1.0 | GO:0035803 | egg coat formation(GO:0035803) |
0.2 | 0.5 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.2 | 1.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.6 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.6 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.2 | 0.5 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 0.8 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.2 | 1.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.7 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.1 | 0.3 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.7 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.1 | 1.5 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.6 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 0.4 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.1 | 3.6 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.8 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) secretory granule localization(GO:0032252) |
0.1 | 0.7 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.8 | GO:0070543 | response to linoleic acid(GO:0070543) |
0.1 | 1.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.7 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 0.8 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 5.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.5 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 0.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 1.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.1 | 0.3 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 1.6 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.7 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.1 | 0.5 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.1 | 7.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.9 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.7 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.1 | 0.6 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.1 | 0.8 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 2.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 1.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 1.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 1.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 1.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.5 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.1 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.6 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.2 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.1 | 0.9 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.5 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.1 | 0.5 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.1 | 0.3 | GO:0050960 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
0.1 | 0.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 3.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 1.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 1.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.2 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.1 | 11.1 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 1.0 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 0.5 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.1 | 0.4 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.6 | GO:0015811 | L-cystine transport(GO:0015811) |
0.1 | 0.3 | GO:0034255 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.1 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.4 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.1 | 0.3 | GO:1904582 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
0.1 | 8.7 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
0.1 | 0.3 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 0.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.6 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.5 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.1 | 0.4 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.1 | 0.4 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.1 | 0.3 | GO:1903487 | regulation of lactation(GO:1903487) |
0.1 | 1.9 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.1 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.1 | 1.4 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.3 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 0.5 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.1 | 0.7 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.1 | 0.6 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.1 | 0.3 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.1 | 0.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.2 | GO:0036292 | DNA rewinding(GO:0036292) |
0.1 | 1.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.3 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 0.2 | GO:0003285 | septum secundum development(GO:0003285) |
0.1 | 0.2 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 6.3 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.7 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.6 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.4 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.1 | 0.6 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.6 | GO:0051917 | regulation of fibrinolysis(GO:0051917) |
0.1 | 0.3 | GO:0032752 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
0.1 | 0.4 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.9 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 2.6 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.2 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.1 | 0.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 2.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.2 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 1.9 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.9 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 1.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 1.9 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.1 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.1 | 0.2 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.1 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.4 | GO:0050893 | sensory processing(GO:0050893) |
0.1 | 0.4 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.1 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 1.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.9 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 2.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.2 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
0.1 | 1.6 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.1 | 0.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.2 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.1 | 0.9 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 1.7 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.2 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.1 | 0.4 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.1 | 0.3 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.7 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 7.8 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 0.4 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.1 | 1.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.1 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.1 | 0.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.8 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.3 | GO:0002860 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 2.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 2.5 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.4 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 3.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.3 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.3 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.3 | GO:0071873 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.0 | 0.6 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.0 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
0.0 | 0.1 | GO:0002519 | natural killer cell tolerance induction(GO:0002519) |
0.0 | 0.8 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.8 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.4 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.0 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.2 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.0 | 0.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.0 | 0.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.0 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.2 | GO:0035624 | receptor transactivation(GO:0035624) |
0.0 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.7 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 1.2 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 1.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.0 | 0.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.0 | 0.5 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
0.0 | 0.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.2 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.0 | 0.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:1904640 | response to methionine(GO:1904640) |
0.0 | 0.6 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.5 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.3 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 1.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.4 | GO:0042262 | DNA protection(GO:0042262) |
0.0 | 0.2 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.0 | 0.2 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.6 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
0.0 | 0.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.0 | 1.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.4 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.0 | 0.3 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.0 | 0.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.3 | GO:0046689 | tyrosine catabolic process(GO:0006572) response to mercury ion(GO:0046689) |
0.0 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.6 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.7 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.1 | GO:0035509 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.0 | 0.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.1 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.2 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.0 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.2 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.0 | 0.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.3 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 2.3 | GO:0031100 | organ regeneration(GO:0031100) |
0.0 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.5 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.3 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 1.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 1.1 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:1900737 | negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.0 | 1.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.1 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.0 | 1.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.8 | GO:0031497 | nucleosome assembly(GO:0006334) chromatin assembly(GO:0031497) |
0.0 | 0.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.7 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 0.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.6 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.0 | 0.4 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.1 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.0 | 0.6 | GO:0016126 | cholesterol biosynthetic process(GO:0006695) sterol biosynthetic process(GO:0016126) secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 1.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 1.7 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.1 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.0 | 0.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.8 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.1 | GO:0072093 | renal vesicle formation(GO:0072033) ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.0 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.8 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.5 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.1 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 1.3 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.5 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 2.0 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.1 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.0 | 0.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.1 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0060371 | response to pyrethroid(GO:0046684) regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.0 | 0.9 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.1 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.0 | 0.3 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.5 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 1.0 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.3 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.0 | 0.7 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.0 | 0.2 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.0 | 0.5 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 0.2 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.0 | 1.0 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.9 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.0 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 0.4 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
0.0 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.2 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
0.0 | 0.2 | GO:1900378 | regulation of melanin biosynthetic process(GO:0048021) positive regulation of melanin biosynthetic process(GO:0048023) regulation of secondary metabolite biosynthetic process(GO:1900376) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 1.6 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 3.1 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0030047 | actin modification(GO:0030047) |
0.0 | 0.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 1.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.1 | GO:0060047 | heart process(GO:0003015) heart contraction(GO:0060047) |
0.0 | 0.3 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.0 | 0.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 2.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.1 | GO:0003095 | pressure natriuresis(GO:0003095) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.4 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 | 0.3 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.0 | 0.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.1 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.0 | 0.2 | GO:2000147 | positive regulation of cell migration(GO:0030335) positive regulation of cellular component movement(GO:0051272) positive regulation of cell motility(GO:2000147) |
0.0 | 0.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 1.2 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.0 | 0.1 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.0 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.0 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.2 | GO:0051493 | regulation of cytoskeleton organization(GO:0051493) |
0.0 | 0.1 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
0.0 | 0.0 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.0 | 0.4 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.3 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.6 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.6 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.3 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.2 | GO:0006954 | inflammatory response(GO:0006954) |
0.0 | 0.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.2 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.0 | 0.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.4 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0009179 | purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) ribonucleoside diphosphate metabolic process(GO:0009185) |
0.0 | 0.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.4 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.2 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.4 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.0 | 0.2 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.5 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.1 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 0.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.4 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.5 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 1.0 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.0 | 1.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.5 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.0 | 0.1 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.3 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.1 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.0 | 1.8 | GO:0098661 | inorganic anion transmembrane transport(GO:0098661) |
0.0 | 0.4 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.2 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 0.0 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.0 | 0.1 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host(GO:0044406) adhesion of symbiont to host cell(GO:0044650) peptide antigen transport(GO:0046968) |
0.0 | 0.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.2 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.2 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.4 | GO:1990748 | cellular detoxification(GO:1990748) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.5 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.8 | 2.4 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.8 | 3.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.8 | 3.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.7 | 4.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.6 | 1.8 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.5 | 1.6 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.5 | 2.6 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.5 | 33.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.5 | 3.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.4 | 16.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.4 | 3.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 1.2 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.4 | 4.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 1.4 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.3 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.3 | 1.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 2.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 3.6 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 1.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 1.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 1.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.9 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.2 | 1.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 0.5 | GO:1990031 | pinceau fiber(GO:1990031) |
0.2 | 3.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 1.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 2.5 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 1.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 1.9 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 0.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 1.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 5.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.4 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.1 | 1.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 1.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 4.6 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.4 | GO:0036028 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.1 | 0.7 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 1.5 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 1.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.6 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.1 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.5 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 2.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 2.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 2.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 0.5 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 0.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.7 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 2.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.1 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.7 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.2 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 0.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 1.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.1 | 0.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.5 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 1.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 1.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.2 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.1 | 0.9 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 1.7 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.1 | 0.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 1.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
0.1 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.8 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.5 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 0.9 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.7 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 1.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 0.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 1.7 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 1.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 8.4 | GO:0030496 | midbody(GO:0030496) |
0.0 | 4.4 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 0.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 10.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.4 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 1.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 2.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 1.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.1 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.0 | 3.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 16.9 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.9 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 1.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.8 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.7 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.7 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 1.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 2.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 1.2 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.5 | GO:0030424 | axon(GO:0030424) |
0.0 | 1.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 1.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.4 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 2.1 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 0.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.0 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.0 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 1.7 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.2 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.8 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 1.5 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.1 | GO:0070761 | PCAF complex(GO:0000125) pre-snoRNP complex(GO:0070761) |
0.0 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.9 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 1.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.0 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.3 | GO:0031526 | brush border membrane(GO:0031526) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.8 | 8.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.7 | 10.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.7 | 3.3 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.6 | 5.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.5 | 1.6 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.5 | 1.4 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.4 | 1.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 2.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 6.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 1.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 1.2 | GO:0061598 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.4 | 1.2 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 2.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 6.2 | GO:0005549 | odorant binding(GO:0005549) |
0.4 | 1.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 1.4 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.3 | 1.0 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.3 | 1.7 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.3 | 2.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 5.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 0.9 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.3 | 3.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 0.9 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.3 | 1.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 1.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 2.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 2.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 0.8 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
0.3 | 0.8 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.3 | 1.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 5.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.2 | 0.9 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.2 | 1.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.2 | 1.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.8 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.2 | 0.6 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.2 | 1.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.6 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.2 | 1.2 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 1.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.7 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.2 | 2.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.7 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.2 | 3.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 1.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 1.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.5 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.2 | 0.8 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.2 | 0.5 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.2 | 0.7 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.2 | 2.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 1.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 9.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.9 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 1.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.4 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.1 | 0.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.4 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 2.6 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.4 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.1 | 0.5 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) polynucleotide phosphatase activity(GO:0098518) |
0.1 | 4.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.4 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.1 | 1.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.8 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.1 | 1.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.9 | GO:0071253 | connexin binding(GO:0071253) gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.1 | 0.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 0.4 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 0.9 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.4 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.1 | 1.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.6 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.1 | 0.2 | GO:0015563 | thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.5 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.1 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.6 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.3 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.1 | 1.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.9 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.4 | GO:0005503 | all-trans retinal binding(GO:0005503) |
0.1 | 0.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 2.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.3 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.1 | 1.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.3 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.1 | 2.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.5 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 2.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.1 | 1.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.6 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.4 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 1.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.3 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
0.1 | 0.4 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.1 | 1.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.4 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.4 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 1.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 0.2 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.1 | 0.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 1.0 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.2 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
0.1 | 2.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 1.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.3 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.1 | 0.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 1.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.2 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.1 | 1.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.4 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.1 | 2.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 1.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.2 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.3 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.1 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 2.3 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.4 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 0.3 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.1 | 0.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 1.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 2.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.2 | GO:0070404 | NADH binding(GO:0070404) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.4 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.4 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 1.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 2.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 2.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 1.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 3.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 4.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 1.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 1.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 17.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 1.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 1.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 1.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.0 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.5 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 2.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 1.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 5.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 1.2 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.1 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.0 | 0.7 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.8 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 0.2 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.0 | 0.7 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 2.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.2 | GO:0035877 | death effector domain binding(GO:0035877) |
0.0 | 6.6 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 1.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.4 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.3 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 3.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0017129 | triglyceride binding(GO:0017129) |
0.0 | 2.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.0 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 1.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.0 | 0.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.0 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.6 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.0 | 0.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 4.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 29.4 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 1.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 1.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.5 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 1.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.0 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 2.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.1 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.0 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.0 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 4.5 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.0 | 0.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.0 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.0 | 1.6 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.7 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 0.1 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 1.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.4 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 1.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 18.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 2.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 3.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 4.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 3.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 4.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 3.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 3.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 3.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 2.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 5.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 2.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 4.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 6.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 1.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 2.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 1.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 1.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 1.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 5.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 4.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 2.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 11.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 4.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 4.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 2.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 3.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 5.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 12.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 2.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 1.8 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 2.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 3.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 1.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 2.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 7.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 4.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.9 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 7.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 2.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 4.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 1.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 1.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 4.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 3.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 1.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 1.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 1.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 2.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 1.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 2.0 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 4.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 1.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 2.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.9 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 1.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 1.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 1.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.8 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 2.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 3.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 1.3 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 1.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 1.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.0 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.3 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 1.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |